UiPath stock: MarketBeat reports USD 15.69 consensus target for UiPath stock

Published on 10/22/2026 at 20:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal second-quarter revenue rose 13.30 percent to USD 410.26 million. UiPath stock costs EUR 12.38 on October 22, 2026 at 8:10 p.m. CEST.

Target and operating figures

MarketBeat reported a USD 15.69 average target from 21 firms on October 21, 2026.
UiPath reported USD 410.26 million in fiscal second-quarter revenue, up 13.30 percent year over year.
UiPath stock costs EUR 12.38 at Lang & Schwarz on October 22, 2026 at 8:10 p.m. CEST.

PATH, US90364P1057, Illustration mit AI erstellt.

UiPath (ISIN US90364P1057) costs EUR 12.38 at Lang & Schwarz on October 22, 2026 at 8:10 p.m. CEST. MarketBeat reported on October 21, 2026 that 21 research firms had a Hold consensus and an average 12-month target of USD 15.69. Against the USD 13.39 opening price cited in the report, that target was 17.18 percent higher.

Revenue reached USD 410.26 million

UiPath's fiscal second-quarter revenue reached USD 410.26 million, up 13.30 percent from the same quarter a year earlier. UiPath also reported annual recurring revenue of USD 1.938 billion as of July 31, 2026, up 12.00 percent year over year, and a dollar-based net retention rate of 109.00 percent.

Analysts balance growth and caution

The consensus figure reflects a divided view rather than a single valuation call. MarketBeat listed four Buy ratings, 15 Hold ratings and two Sell ratings on October 21, 2026. The same report said fiscal second-quarter earnings per share were USD 0.15, matching the consensus estimate, while revenue exceeded the USD 397.77 million forecast.

UiPath calendar carries two dates

UiPath listed its Investor Day on September 22, 2026 and the NCQA Health Innovation Summit from October 4 to October 7, 2026. The events page also identifies the fiscal second-quarter results conference call as June 25, 2026.

Valuation remains tied to execution

MarketBeat listed a USD 6.98 billion market capitalization, a P/E ratio of 19.99 and a 52-week range of USD 9.20 to USD 19.84 on October 21, 2026. Those figures put the analyst debate alongside a measurable operating record: revenue growth reached 13.30 percent, while annual recurring revenue grew 12.00 percent through July 31, 2026.

UiPath stock at Lang & Schwarz

The stock was trading at EUR 12.38 at Lang & Schwarz on October 22, 2026 at 8:10 p.m. CEST. The euro quote is the latest investor-facing indication for the German trading session.

The further course of trading is shown by the continuously updated real-time quote of UiPath stock.